Skip to main content
Caplight Logo









Creasallis

Creasallis

Private
CambridgeHealthcare & Life Scienceshttps://creasallis.com/

Last Round

Pre Seed

Mar 24, 2026

Total Funding Raised

$1.01M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Creasallis is a biotechnology company that develops innovative antibody engineering solutions to improve the penetration of therapeutic antibodies into solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antibody engineeringbiotechnologysolid tumordrug deliveryoncology therapeuticsprotein engineeringbiologicstherapeutic indexinvestigational new drugINDtumor microenvironmentdrug discoverybiotech platformprecision medicinedrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Creasallis Comparables

Compare Creasallis with similar companies based on industry and business-model similarity.

Creasallis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AbTx
79%
Avidicure
72%
Neobe Therapeutics
65%

Creasallis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 24, 2026
Pre SeedJan 26, 2023
AcceleratorSep 27, 2021

Key People

Founding team and executive leadership

Zahra Jawad

CEO and founder

Founding Team

Creasallis Investors

Notable investors and investment history

Creasallis investors
InvestorRounds
BlueYard CapitalPre Seed
ZAKA VCPre Seed
Accelerate@BabrahamAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Monthly visitors grew 291% MoM, from 329 to 1.3K.

  • Mar 24, 2026

    $1M raised in Pre Seed round.

Creasallis Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Creasallis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Creasallis's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range3
Year Founded2021
Last FundingMar 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?